SCHEMBL14038583

SCHEMBL14038583

COc1cc(C(=O)C2=Cc3cccc(OO)c3OC2)cc(OC)c1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.57
KMT2A Q03164 3/20 0.54
MAPT P10636 2/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
POLB P06746 1/20 0.50
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TP53 P04637 2/20 0.49
MEN1 O00255 2/20 0.46
ALDH1A1 P00352 1/20 0.45
TUBB4A P04350 7/20 0.42
TUBB P07437 7/20 0.42
TUBA3C P0DPH7 7/20 0.42
TUBA1B P68363 7/20 0.42
TUBA4A P68366 7/20 0.42
TUBB4B P68371 7/20 0.42
TUBB3 Q13509 7/20 0.42
TUBB2A Q13885 7/20 0.42
TUBB8 Q3ZCM7 7/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13270233 0.88 NR1H4 (0.54) NR1H4KMT2AMAPTNPC1RAB9A
SCHEMBL3138277 0.87 NR1H4 (0.58) NR1H4KMT2AMAPTNPC1RAB9A
SCHEMBL14013667 0.86 NR1H4 (0.53) NR1H4KMT2AMAPTNPC1RAB9A
SCHEMBL3141244 0.83 NR1H4 (0.47) NR1H4KMT2AMAPTNPC1RAB9A
SCHEMBL3127787 0.81 NR1H4 (0.51) NR1H4KMT2AMAPTNPC1RAB9A
SCHEMBL3136921 0.81 NR1H4 (0.55) NR1H4KMT2AMAPTNPC1RAB9A
SCHEMBL13270529 0.80 NR1H4 (0.53) NR1H4KMT2AMAPTNPC1RAB9A
SCHEMBL3137512 0.77 NR1H4 (0.42) NR1H4KMT2AMAPTTP53ALDH1A1
SCHEMBL3135730 0.76 MAPT (0.46) NR1H4MAPTSMN1; SMN2ALDH1A1TUBB4A
SCHEMBL9058215 0.75 KMT2A (0.70) NR1H4KMT2AMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7456214-B2 Cancer; for selectively destroying tumor vasculature; inhibit tubulin polymerization; selectively reducing blood flow to at least a portion of a neoplastic region; 3-(3',4',5'-Trimethoxybenzoyl)-6-hydroxy-7-methoxy-2H-chromene BAYLOR UNIVERSITY (US) 2008-11-25 US disclosed